Shanghai Shen Lian Biomedical Corporation (SHA:688098)
9.97
+0.01 (0.10%)
Jan 23, 2026, 3:00 PM CST
Shanghai Shen Lian Biomedical Company Description
Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China.
It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China.
Shanghai Shen Lian Biomedical Corporation
| Country | China |
| Founded | 2001 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 391 |
| CEO | Zhen Zhang |
Contact Details
Address: No. 48 Jiangchuan East Road Shanghai, 200241 China | |
| Phone | 86 21 6125 7979 |
| Website | slbio.com.cn |
Stock Details
| Ticker Symbol | 688098 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100003P17 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dongsheng Nie | Chairman of the Board of Directors and Director of Research & Development Center |
| Zhen Zhang | General Manager |
| Xun Liu | Financial Director |
| Bo Yin | Technical Director |
| Haixia Yu | Board Secretary |
| Jie Wu | Accounting Supervisor |
| Wen Hao Nie | Deputy GM and Director |
| Gui Jun Ma | Director and Core Technician of Research & Development Center |